Nectar Lifesciences Limited has informed the Exchange with copy of minutes of Postal Ballot
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nectar Lifesciences Limited has filed the minutes of its postal ballot conducted through electronic voting from January 30, 2026 to February 28, 2026, with results declared on March 1, 2026. All three resolutions were approved with overwhelming majority: (1) appointment of Mr. Sushil Kapoor as a Director liable to retire by rotation (99.99% in favor), (2) his appointment as Wholetime Director designated as Director (Finance) for three years effective December 4, 2025 (99.99% in favor), and (3) adoption of a new Memorandum of Association with amended object clause (99.08% in favor). Mr. Kapoor's remuneration was fixed at ₹3 lakh per month plus a one-month salary bonus annually and standard benefits. The promoter group holding ~10.07 crore shares (about 52% of the company) voted 100% in favor of all resolutions, while public institutional investors unanimously opposed the MOA amendment (100% against).
The company has formally locked in a three-year finance director appointment and widened its permitted business activities via the MOA amendment, giving it room to diversify. The unanimous promoter backing signals management stability, but the unusual 100% opposition from public institutional holders on the MOA change may raise governance questions among minority investors.